Search

Novavax Inc

Lezárt

SzektorEgészségügy

9.43 6.43

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

8.26

Maximum

8.97

Fő mutatók

By Trading Economics

Bevétel

-44M

-53M

Értékesítés

-83M

57M

P/E

Szektor átlag

3.112

57.371

Egy részvényre jutó nyereség

-0.32

Profit margin

-94.16

Munkavállalók

749

EBITDA

-39M

-40M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

+48.21% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

113M

1.3B

Előző nyitás

3

Előző zárás

9.43

Hangulat hírek alapján

By Acuity

13%

87%

17 / 340 Rangsor szerint Healthcare

Novavax Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 24. 20:04 UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

2026. aug. 21. 23:31 UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

2026. aug. 20. 19:02 UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

2026. aug. 19. 23:51 UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

2026. aug. 17. 19:36 UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

2026. aug. 14. 23:26 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

2026. aug. 13. 19:16 UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

2026. aug. 12. 23:31 UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

2026. aug. 11. 23:51 UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

2026. aug. 10. 23:46 UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

2026. aug. 7. 19:36 UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

2026. aug. 6. 23:01 UTC

News

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

2026. aug. 5. 23:01 UTC

Novavax shares are higher in after-market trading, though they remain below the 20-day moving average amid weaker-than-expected U.S. job growth data.

2026. aug. 4. 23:36 UTC

Novavax Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average. Broader market sentiment may support this upward movement.

2026. aug. 3. 23:46 UTC

News

Novavax Inc is advancing in after-market trading as it shifts focus to licensing its Matrix-M adjuvant, attracting positive retail investor sentiment ahead of earnings.

2026. júl. 31. 19:16 UTC

Novavax Inc. shares are lower today, reflecting a decline from Thursday's close amid rising bond yields and crude oil prices contributing to inflation concerns.

2026. júl. 30. 22:01 UTC

Novavax Inc. shares advanced in after-market trading, rebounding from earlier session lows, though they remain below the 20-day moving average.

2026. júl. 29. 23:06 UTC

Novavax Inc. shares are higher in after-market trading, gaining slightly since Wednesday's close, despite broader market weakness and significant declines over the past month.

2026. júl. 28. 16:06 UTC

Novavax Inc. shares are lower today, reflecting broader market declines amid investor caution ahead of earnings and the Federal Reserve's interest rate decision.

2026. júl. 27. 14:02 UTC

Novavax Inc shares are higher in pre-market trading, rising to $7.73. This increase occurs amid three consecutive lower session closes and mixed economic data.

2026. júl. 24. 18:46 UTC

Novavax Inc. shares are lower today, continuing a trend of declines following three consecutive sessions of lower closes and trading below the 20-day moving average.

2026. júl. 23. 09:01 UTC

Novavax Inc shares are higher in pre-market trading, reflecting upward momentum since Wednesday. Broader market sentiment remains positive amid rising Asian equity indices.

2026. júl. 22. 23:11 UTC

Novavax Inc. shares are higher in after-market hours, driven by strength in biotechnology stocks. The company remains below its 20-day moving average.

2026. júl. 21. 22:46 UTC

Novavax Inc. shares declined in after-market trading, remaining below their 20-day moving average despite a broader market rebound in the tech sector.

2026. júl. 20. 23:46 UTC

Novavax Inc. shares traded roughly flat after-market with no specific news identified. The stock remains significantly below its 20-day moving average.

Társak összehasonlítása

Árváltozás

Novavax Inc Előrejelzés

Célár

By TipRanks

48.21% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 13.25 USD  48.21%

Magas 19 USD

Alacsony 7 USD

4 Wall Street elemző 12 hónapos célárain alapulva a(z)Novavax Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

4 ratings

2

Vétel

1

Tartás

1

Eladás

Hangulat

By Acuity

17 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
help-icon Live chat